Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.34 USD | -1.99% | +3.80% | -2.26% |
Apr. 04 | Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing | MT |
Mar. 18 | North American Morning Briefing : Investors -2- | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 44.94M | Capitalization | 1.31B |
---|---|---|---|---|---|
Net income 2024 * | -57M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | 139M | Net cash position 2025 * | 99.6M | EV / Sales 2025 * | 27 x |
P/E ratio 2024 * |
-25.2
x | P/E ratio 2025 * |
-52.2
x | Employees | 33 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.95% |
Latest transcript on Soleno Therapeutics, Inc.
1 day | -1.99% | ||
1 week | +3.80% | ||
Current month | -8.08% | ||
1 month | -6.36% | ||
3 months | -15.05% | ||
6 months | +63.37% | ||
Current year | -2.26% |
Managers | Title | Age | Since |
---|---|---|---|
Anish Bhatnagar
CEO | Chief Executive Officer | 56 | 05-12-31 |
James Mackaness
DFI | Director of Finance/CFO | 60 | 19-11-13 |
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ernest Mario
CHM | Chairman | 85 | 07-08-02 |
Gwen Melincoff
BRD | Director/Board Member | 72 | 19-04-25 |
Bill Harris
BRD | Director/Board Member | 65 | 14-06-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 39.34 | -1.99% | 335,907 |
24-04-23 | 40.14 | +6.93% | 416,661 |
24-04-22 | 37.54 | +0.11% | 369,120 |
24-04-19 | 37.5 | +0.94% | 191,129 |
24-04-18 | 37.15 | -1.98% | 262,210 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.26% | 1.31B | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.86% | 22.2B | |
-16.53% | 21.23B | |
-8.49% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- SLNO Stock